Pen Needles Market to Hit USD 3.08 Billion by 2030 with 9.2% CAGR | MarketsandMarkets™
The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 ...
Over half of Type 1 diabetes patients feel their daily lives are restricted, survey shows
A recent survey found that more than half of people living with Type 1 diabetes say the condition has an impact on their ...
Most Type 1 diabetes patients feel lives are restricted due to their condition, survey finds
Type 1 diabetes (T1D) is an autoimmune condition where the body cannot produce insulin properly, and this can affect the life ...
Embecta raises FY2025 adjusted EBITDA margin guidance to 37% amid cost-cutting and debt reduction focus
Adjusted EBITDA margin increased to 37.2% from 25.2% in Q4 2024, driven by cost reductions and operational improvements. Management's tone shifted positively, highlighting stronger-than-expected ...
More than half of adults with ‘relentless’ condition say it stops them being spontaneous
MORE than half of adults living with type 1 diabetes believe the condition stops them from being more spontaneous. A poll of ...
Half of adults with Type 1 diabetes say condition limits spontaneity
A recent survey found that more than half of adults living with Type 1 diabetes believe the condition limits their ability to be spontaneous ...
Medtronic: Undervalued But Underperforming - Why Innovation Isn't Enough To Lift The Stock
Medtronic's stock lags peers due to growth challenges in the diabetes and hypertension markets. See why we recommend a sell ...
Embecta Corp. (NASDAQ:EMBC) Q1 2025 Earnings Call Transcript
Q1 2025 Earnings Call Transcript February 6, 2025 Embecta Corp. beats earnings expectations. Reported EPS is $0.65, ...
Zacks.com on MSN9d
JBL Boosts Healthcare Portfolio With Strategic Buyout: Stock to Gain?
Jabil acquires Pharmaceutics International to enhance commercial prospects in the emerging market of CDMO services.